Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion

Clinical and Experimental Ophthalmology

Volumn 37, Issue 5, 2009, Pages 490-495

  Park, Sung P ^a   Ahn, Jae K ^b  

^a Hallym University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Bevacizumab; Branch retinal vein occlusion; Ischaemic macular oedema; Pigment epithelium derived factor; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PROGNOSIS; PROTEIN SECRETION; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; AQUEOUS HUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PROGNOSIS; RETINAL VEIN OCCLUSION; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67651155889     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02061.x     Document Type: Article

References (15)

1. Noma H, Funatsu H, Yamasaki M et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140: 256-61.
2. Park SP, Ahn JK. Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion. Clin Experiment Ophthalmol 2008; 36: 831-5.
3. Barnstable CJ, Tombran-Tink J. Neuroprotective and anti-angiogenic actions of PEDF in the eye: Molecular targets and therapeutic potential. Prog Retin Eye Res 2004; 23: 561-77.
4. Liu H, Ren RG, Cooper WL, Hawkins CE, Cowan MR, Tong PY. Identification of antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci U S A 2004; 101: 6605-10.
5. Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ. Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1241-7.
6. Pai SA, Shetty R, Vijayan PB et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007; 143: 601-6.
7. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007; 27: 419-25.
8. Wu L, Arevalo JF, Roca JA et al. Comparison of two doses of intravitreal bevacizumab(avastin) for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2008; 28: 212-19.
9. Kreutzer TC, Alge CS, Wolf AH et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2008; 92: 351-5.
10. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113: 1538-44.
11. Chen SD, Sundaram V, Lochihead J, Patel CK. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006; 141: 876-83.
12. Boehm BO, Lang G, Volpert O et al. Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia 2003; 46: 394-400.
13. Funatsu H, Yamashita H, Nakamura S, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2006; 113: 294-301.
14. Rehak M, Hollborn M, Iandiev I, et al. Retinal gene expression and Muller cell response after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci 2009; 50: 2359-67.
15. Ohno-Matsui K, Yoshida T, Uetama T, Mochizuki M, Morita I. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun 2003; 303: 962-7.